MINOIA, Mariella
 Distribuzione geografica
Continente #
NA - Nord America 1.785
EU - Europa 420
AS - Asia 331
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 2.543
Nazione #
US - Stati Uniti d'America 1.785
CN - Cina 205
UA - Ucraina 125
DE - Germania 110
TR - Turchia 75
GB - Regno Unito 54
IT - Italia 51
SG - Singapore 46
SE - Svezia 33
FI - Finlandia 32
RU - Federazione Russa 10
BE - Belgio 5
BR - Brasile 2
EU - Europa 2
VN - Vietnam 2
CL - Cile 1
EC - Ecuador 1
ID - Indonesia 1
IN - India 1
IR - Iran 1
NZ - Nuova Zelanda 1
Totale 2.543
Città #
Woodbridge 246
Chandler 184
Fairfield 178
Houston 170
Ashburn 167
Jacksonville 147
Wilmington 82
Ann Arbor 81
Seattle 73
Cambridge 64
Addison 47
Izmir 42
Nanjing 37
Singapore 33
Princeton 30
Shanghai 28
Dearborn 27
Beijing 25
Boardman 25
Bremen 23
Ferrara 20
Milan 19
Shenyang 16
Jinan 13
Nanchang 13
Changsha 12
San Diego 11
New York 10
Tianjin 10
Falls Church 8
Hebei 7
Mountain View 7
Indiana 6
Los Angeles 6
Auburn Hills 5
Brussels 5
Jiaxing 5
Kunming 5
Orange 5
Washington 5
Ningbo 4
Tappahannock 4
Guangzhou 3
Hefei 3
Helsinki 3
Lanzhou 3
London 3
Norwalk 3
Padova 3
Chengdu 2
Des Moines 2
Dong Ket 2
Redwood City 2
Xian 2
Ardabil 1
Baotou 1
Bologna 1
Canaro 1
Changchun 1
Chongqing 1
Formia 1
Fuzhou 1
Haikou 1
Hangzhou 1
Harbin 1
Jakarta 1
Kilburn 1
Mumbai 1
Munich 1
Navegantes 1
Rome 1
San Francisco 1
San Mateo 1
Shaoxing 1
Taiyuan 1
Taizhou 1
Tomsk 1
Tosagua 1
Totale 1.960
Nome #
Effect of Everolimus on Cell Viability in Nonfunctioning Pituitary Adenomas 160
Magmas Overexpression Inhibits Staurosporine Induced Apoptosis in Rat Pituitary Adenoma Cell Lines 157
Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids 132
Cyclin D1 levels are involved in the resistance to m-TOR inhibitors in human bronchial carcinoids 130
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression. 114
Epidermal growth factor pathway as a possible target in the medical therapy of bronchial carcinoids 114
Growth hormone excess promotes breast cancer chemoresistance 106
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression 106
Growth Hormone Enhances Breast Cancer Chemoresistance by Inhibiting JNK-Mediated Apoptosis 104
Growth Hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines 100
Mitotane reduces human and mouse ACTH-secreting pituitary cell viability and function. 92
Cabergoline reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 91
Growth hormone induces chemoresistance in breast cancer cells 90
Effects of mTOR inhibitors in the control of non functioning pituitary adenomas cell growth 85
Growth Hormone enhances breast cancer chemoresistance by protecting from apoptosis 77
Differential mTOR and PI3K Pathway Activation in Human Bronchial Carcinoids 75
GH enhances breast cancer chemoresistance by inhibiting JNK-mediated apoptosis 74
Everolimus reduces human ACTH secreting pituitary adenoma in vitro cell viability by inhibiting IGF-I down-stream signalling 73
GH influences breast cancer chemoresistanec independently of cell cycle perturbations 72
Bronchial carcinoid response to mTOR inhibitors depends on mTOR expression levels 68
Cyclo-oxygenase 2 modulates chemoresistance in breast cancer cells involving NF-kB. 68
mTOR inhibitors hamper cell viability in selected human medullary thyroid carcinoma primary cultures 67
Everolimus reduces human ACTH-secreting pituitary adenoma in vitro cell viability 67
GH protects breast cancer cells from chemotherapy by blocking cytotoxic-induced apoptosis in estrogen receptor negative breast cancer cells 64
Evaluation of PKC isoforms expression in thyroid cells lines and effects of a PKC beta II selective inhibitor 59
mTOR inhibition influences cell viability of human bronchial carcinoids in vitro 52
mTOR inhibition influences cell viability of medullary thyroid carcinoma primary cultures 49
null 44
null 40
mTOR inhibition hampers cell viability in selected human medullary thyroid carcinoma primary cultures 20
miR-26a Plays an Important Role in Cell Cycle Regulation in ACTH-Secreting Pituitary Adenomas by Modulating Protein Kinase C  18
Totale 2.568
Categoria #
all - tutte 10.734
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.734


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020438 0 14 15 74 38 87 43 50 37 64 7 9
2020/2021364 30 22 30 75 6 35 16 41 10 35 42 22
2021/2022288 7 35 13 2 8 18 14 6 6 29 41 109
2022/2023387 33 41 18 55 64 52 20 26 48 4 12 14
2023/2024209 15 16 8 6 18 37 8 53 5 2 2 39
2024/202525 16 9 0 0 0 0 0 0 0 0 0 0
Totale 2.568